title: Chronic kidney disease: psychosocial impact of chronic pain.
abstract: Chronic kidney disease (CKD) affects more than 19 million people in the United States, and prevalance of CKD is expected to double within 10 years. Additionally, a significant number of predominantly elderly patients have end stage renal disease, necessitating dialysis or kidney transplant. Perception of chronic pain, especially in elderly dialysis patients, may be greatly underrecognized. As a result management of pain, as well as depression, and other physical and mental symptoms, may not be adequately addressed in the primary care setting. Clinical interventions such as psychiatric evaluation, pain management, and therapy to improve physical and mental symptoms, may markedly impact wellbeing for CKD patients. Constant reassessment is critical when treating CKD patients. Such an approach may significantly better elderly patients health-related quality of life.
authors.affiliation: Division of Nephrology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
authors.forename: Sara N
authors.initials: SN
authors.lastname: Davison
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000928:Antidepressive Agents / Q000627:therapeutic use; D003866:Depressive Disorder / Q000188:drug therapy / Q000209:etiology; D005853:Geriatrics; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications / Q000523:psychology* / Q000628:therapy; D016030:Kidney Transplantation; D008875:Middle Aged; D010146:Pain / Q000209:etiology / Q000523:psychology*; D011610:Psychosocial Deprivation; D011788:Quality of Life; D006435:Renal Dialysis; D017367:Selective Serotonin Reuptake Inhibitors / Q000378:metabolism / Q000627:therapeutic use; D012720:Severity of Illness Index
chemical_list: D000928:Antidepressive Agents; D017367:Selective Serotonin Reuptake Inhibitors